Bugworks Research, a clinical-stage biopharmaceutical company, has engaged Dr. Renu Swarup as a honorary member of the Global Advisory Board. Dr. Swarup is the former Secretary, Department of Biotechnology, Government of India and brings in more than three decades of experience in the biotech sector. As the Member Secretary of the Expert Committee, Dr. Swarup oversaw the formulation of…
Bugworks Research, a clinical stage multi-indication therapeutics company, announced the financing of US$18M Series B1. This round will support the clinical development of BWC0977, a novel broad spectrum anti-bacterial agent available in both IV and Oral forms, and the pre-clinical development of its best-in-class Adenosine immuno-oncology asset, according to the company’s statement. The Series B1…
Bugworks Research, a Biopharma startup, announced that it has raised $7.5 million (Rs 57.30 crore) in a fresh funding round, led by University of Tokyo Edge Capital and Global Brain Corporation, along with South Africa-based Acquipharma Holdings, the Bengaluru and Delaware-based company announced on Thursday. With the closure of the transaction, the startup, which also…